For instance, in invasive breast cancer cell lines, overexpression of EMT-related TFs including Twist, Snail, and FOXC2 results in an increase in the promoter activity and expression of ABC transporters, thereby enhancing resistance to doxorubicin treatment [117]. This evidence concerns the gene TWIST1 and breast carcinoma.